Disseminated superficial porokeratosis and pyoderma gangrenosum.
Disseminated Superficial Actinic Porokeratosis (DSAP) is usually triggered by sun exposure. In some cases sun exposure is not essential and this skin disease is related to immunosuppression. Many associated diseases are described in the literature. We report a clinical case of a patient affected by pyoderma gangrenosum, who developed DSAP.
Nicola
N
di Meo
Catharina
C
Fluehler
Valentina
V
Perkan
Giusto
G
Trevisan
D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D006801:Humans; D007868:Leg Dermatoses / Q000188:drug therapy / Q000209:etiology; D007869:Leg Injuries / Q000150:complications; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D017499:Porokeratosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D017511:Pyoderma Gangrenosum / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D012883:Skin Ulcer / Q000209:etiology / Q000473:pathology
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002991:Clofazimine; D008775:Methylprednisolone